Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

苏麦达 - NMPA Drug Approval Details

Approvals/NMPA/苏麦达

Approved

化学药品

苏麦达

OTSUKA PHARMACEUTICAL CO., LTD.🇨🇳 National Medical Products Administration

Approval Date: Sep 30, 2025
Approval ID: 8nbPyNWsp7G
Company: OTSUKA PHARMACEUTICAL CO., LTD.
Type: 化学药品

Approval Details

Approval Id: 8nbPyNWsp7G
Approval Number: 国药准字HJ20250121
Generic Name: 注射用托伐普坦磷酸钠
Trade Name: 苏麦达
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 16mg
Reg Date: 2025-09-30
Expired Date: 2030-09-29
Company Name: OTSUKA PHARMACEUTICAL CO., LTD.
Company Detail Path: /organization/otsuka-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 30, 2025

Approval ID

8nbPyNWsp7G

Type

化学药品

Back to NMPA Approvals